Skip to main content
. 2020 Jul 21;42(4):573–584. doi: 10.1038/s41401-020-0473-8

Fig. 8. The proposed working model of matrine on pathological cardiac fibrosis.

Fig. 8

Matrine treatment increased RPS5 expression, which subsequently decreased profibrotic stimulation-induced p38 phosphorylation and alleviated fibrotic remodeling and cardiac dysfunction.